This concept is supported by the fact that mutations in PANK2, encoding the first enzyme in the CoA synthesis, approximately account for 50% of NBIA cases, classified as PKAN (Pantothenate Kinase Associated Neurodegeneration) 7, 8. The gene discussed is PANK2; the disease is neurodegeneration with brain iron accumulation.